Equities

Sativus Tech Corp

SATT:PKC

Sativus Tech Corp

Actions
  • Price (USD)0.29
  • Today's Change0.00 / 0.00%
  • Shares traded508.00
  • 1 Year change-12.09%
  • Beta0.8996
Data delayed at least 15 minutes, as of Jun 04 2024 18:11 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sativus Tech Corp. is an agriculture technology company. The Company, through its subsidiary, Saffron-Tech Ltd. (Saffron Tech), is focusing on development of agriculture and technological products, in the fields of exotic plants and mushrooms. The Company is focused on developing and testing a fully automated and remotely managed system for growing saffron and other vegetables. Saffron Tech has developed an agronomic and agrotechnical protocol for the cultivation of saffron. The Company is in advanced stages of developing and testing a fully automated and remotely managed system for growing saffron anywhere and anytime. Saffron is used in many industries, such as the food industry, particularly by famous chefs and Michelin starred restaurants, the natural cosmetics industry, and the food supplements industry and as a dye in the textile industry.

  • Revenue in USD (TTM)0.00
  • Net income in USD-68.00k
  • Incorporated2015
  • Employees--
  • Location
    Sativus Tech Corp#3 Bethesda Metro Center #700BETHESDA 06880United StatesUSA
  • Phone+1 (203) 307-1179
  • Fax+1 (302) 658-3694
  • Websitehttps://sativus-tech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Health Advance Inc-100.00bn-100.00bn1.19m3.00--0.3026----------0.0212----------------------------0.0356--100.00---21.75------
Respirerx Pharmaceuticals Inc0.00-2.17m1.21m2.00---------0.014-0.0140.00-0.04120.00----0.00-2,255.78-2,491.69---------------2.90---------12.78------
Vestiage Inc0.00-21.76k1.22m0.00---------0.0004-0.00040.00-0.00110.00-------4,945.46---------------------------102.30------
Yield10 Bioscience Inc300.00k-13.15m1.23m29.00------4.09-146.30-146.301.06-123.900.0627----10,344.83-274.51-91.26-2,396.54-108.09-----4,381.67-2,279.74---------86.67-35.94-6.55--1.84--
Bespoke Extracts Inc785.45k-1.48m1.30m10.00------1.66-0.1458-0.14580.0774-0.16962.0655.9934.7378,545.00-388.21------43.69---188.79--0.0612-135.42----22,933.72--63.98------
Sativus Tech Corp0.00-68.00k1.35m-----------0.0483-0.04830.00-0.52380.00-------18.8325.48----------------5.41------78.78------
Aoxing Pharmaceutical Company Inc30.11m-1.46m1.36m339.00--0.016--0.0453-0.0192-0.01920.39510.25070.4962.322.56---2.41-14.54-7.06-35.4576.1968.51-4.85-37.690.73680.33870.6052--26.8837.20-62.49---38.80--
LadRx Corp0.001.66m1.37m2.000.80143.960.8170--3.443.440.000.69730.00----0.0096.28-58.97---78.44------------0.00------106.96------
Nexien Biopharma Inc0.00-246.18k1.38m0.00---------0.0038-0.00380.00-0.00480.00-------679.40-860.53---1,653.53-----------1.77--------42.22------
Agentix Corp0.00-1.01m1.42m-----------0.0253-0.02530.00-0.0710.00-------907.08-----------------96.41----------------
Lucy Scientific Discovery Inc16.73k-9.76m1.46m----17.96--87.14-6.34-7.210.01030.0460.0037--0.7276---215.45------49.97---58,360.55-----5.100.4615-------53.49------
Virpax Pharmaceuticals Inc0.00-16.89m1.48m7.00---------14.42-14.420.00-1.040.00----0.00-156.21-87.52-241.52-116.56--------------------29.84------
180 Life Sciences Corp0.00-16.24m1.53m4.00---------41.54-41.540.00-1.120.00----0.00-176.90-42.39-354.57-56.41-----------385.88--------48.52------
Bluejay Diagnostics Inc0.00-9.74m1.54m10.00--0.4232-----7.68-7.680.001.250.00----0.00-122.06---149.68--------------0.0048---100.00---7.07------
Data as of Jun 04 2024. Currency figures normalised to Sativus Tech Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.